Traphaco JSC (HOSE:TRA)

Market Cap	3.10T
Revenue (ttm)	2.35T
Net Income (ttm)	194.59B
Shares Out	41.45M
EPS (ttm)	4,713.87
PE Ratio	15.89
Forward PE	n/a
Dividend	4,000.00 (5.34%)
Ex-Dividend Date	Jan 3, 2025

Volume	621
Average Volume	5,619
Open	74,900
Previous Close	73,300
Day's Range	74,600 - 74,900
52-Week Range	65,000 - 86,800
Beta	0.16
RSI	46.67
Earnings Date	Apr 29, 2025

About Traphaco JSC

Traphaco Joint Stock Company, together with its subsidiaries, engages in the production and trade of pharmaceutical products, chemicals, medical supplies, and equipment in Vietnam. It is involved in the production of medicines to treat human diseases, nutritional food products, and medicines derived from medicinal herbs; trade of medicines, pharmaceuticals, vaccines-biological products, chemicals, and nutritional food products; and planting medicinal plants; and processing medicinal herbs. The company also engages in exporting and importing of ...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 1,670
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: TRA

Financial Performance

In 2024, Traphaco JSC's revenue was 2.35 trillion, an increase of 2.09% compared to the previous year's 2.30 trillion. Earnings were 206.83 billion, a decrease of -9.60%.